Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avecho Biotechnology Ord Shs V.AVE


Primary Symbol: AVEFF

Healthcare
Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.


OTCPK:AVEFF - Post by User

Avecho Biotechnology Ord Shs
Bullboard Posts
User Avatar Image
(0)
•••
Comment by zadmanon Aug 05, 2017 11:50am
88 Views
Post# 26550902

RE:RE:001 - Anon seller all summer (no breadth in sellers)

RE:RE:001 - Anon seller all summer (no breadth in sellers)What did they know last quarter?  2.4mm positive EBITDA - annualize that to 10 mil for rough figures means we trade at 1.8x EBITDA.  I don't really see how this goes much lower unless rig counts collapse and the 2.4MM quarterly EBITDA tanks again.

i fully agree with you price is truth but there's more to this than someone merely expressing a negative viewpoint of the stock.  Personally, I like disclosure of a short position because those shares  are already sold and have to be covered at some point.  In an illiquid stock, this position could turn against the shorter quickly and become a house of pain on he upside with limited shares on the ask and the shorter competing with new longs.  10 days till Q2 will tell us more.....


zad
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities